ARCHIVES

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

May 29, 2009

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000

NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available

October 5, 1984

Training Grants Are Back; IGMS Implements New Program, With Awards To Be Made In June

January 24, 1975

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006